Doxycycline (Cyclidox Ec)
Doxycycline
Viatris South Africa (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Viatris South Africa (Pty) Ltd
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cyclidox ec 50 MG capsules EACH CAPSULE CONTAINS DOXYCYCLINE HYDROCHLORIDE EQUIVALENT TO 50 mg DOXYCYCLINE | 50 mgCapsules | 28000428/20.1.1/0004 | Cancelled | Not determined | None |
| Cyclidox ec 100 MG capsules EACH CAPSULE CONTAINS DOXYCYCLINE HYDROCHLORIDE EQUIVALENT TO 100 mg DOXYCYCLINE | 100 mgCapsules | 28000528/20.1.1/0005 | Cancelled | Not determined | None |
| Cyclidox ec 200 MG capsules EACH CAPSULE CONTAINS DOXYCYCLINE HYDROCHLORIDE EQUIVALENT TO 200 mg DOXYCYCLINE | 200 mgCapsules | 28000628/20.1.1/0006 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Doxycycline
- when intended and labelled for the chemoprophylaxis of malaria in those aged 8 years and older. (S2)
- in preparations thereof for the treatment of animals and registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Consolidated Schedules 06 July 2026, lines 6118 to 6123
S2: Doxycycline
- when intended and labelled for the chemoprophylaxis of malaria in those aged 8 years and older. (S4)
Consolidated Schedules 06 July 2026, lines 1873 to 1875
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(4S,4AR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
Drag to rotate. Structure from PubChem CID 54671203.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.